Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Custom sound therapy shows promise for ringing ears

NCT ID NCT07637708

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a personalized sound therapy for adults with chronic tinnitus, a condition where people hear ringing or buzzing without an external source. 25 participants received either music embedded with tones matched to their tinnitus frequency or low-frequency sounds. The goal was to see if the personalized therapy could reduce tinnitus severity more effectively than the comparison treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized music-embedded sound therapy
What this could lead to
If it works, this could offer a new, non-invasive way to reduce the severity of chronic tinnitus and improve quality of life.
What could go wrong
This was a small, early-stage trial with only 25 participants, so results may not apply to everyone. The therapy may not work for all types of tinnitus.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Oct 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 18 to 75 years. Diagnosis of chronic subjective tinnitus lasting more than 6 months. Non-pulsatile tinnitus. Tonal tinnitus with an identifiable tinnitus frequency. Unilateral or bilateral tinnitus. Ability to understand the study procedures and provide written informed consent. Ability to comply with the assigned sound therapy protocol and follow-up assessments. Exclusion Criteria: Pulsatile tinnitus. Non-tonal tinnitus. History of auditory hallucinations. History of Ménière's disease. History of other active middle or inner ear disease with neurological sequelae. Current use of centrally acting medications that could interfere with tinnitus perception or auditory processing. Severe hearing loss preventing adequate perception of the auditory stimuli. Inability to complete the follow-up assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic subjective tinnitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clínico Universidad de Chile

    Santiago, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.